Regional citrate anticoagulation with 4% sodium citrate
DOI: https://dx.doi.org/10.18565/nephrology.2023.2.57-61
Avetisyan E.A., Kostritsa N.S.
National Medical Research Center of Cardiology n.a. Acad. E.I. Chazov, Moscow, Russia
The choice of the method of anticoagulation during various extracorporeal procedures is relevant in view of the increasing frequency of the use of this procedure by doctors of various specialties. Regional citrate anticoagulation (RCA) has a number of advantages over systemic anticoagulation with heparin, including: longer filter life in renal replacement therapy (RRT), lower risk of bleeding. In order to achieve maximum efficiency and safety of RCA, many different citrate dosing algorithms have been proposed; protocol citrate anticoagulation with 4% sodium citrate is the most studied. This literature review discusses the main studies evaluating the efficacy and safety of this technique. Currently, research results allow professional communities to recommend CAR as the method of choice for extended RRT.
About the Autors
Erik A.Avetisyan – Cardiologist at the Intensive Care Unit of the Department of Emergency Cardiology, National Medical Research Center of Cardiology n.a. Acad. E.I. Chazov.Address: 15a Academician Chazov st., Moscow, 121552. ORCID: 0000-0002-9660-9851.
Natalya S. Kostritsa – Cardiologist, Resident at the Intensive Care Unit of the Department of Emergency Cardiology, National Medical Research Center of Cardiology n.a. Acad. E.I. Chazov. Address: 15a Academician Chazov st., Moscow, 121552; e-mail: nataliakostritsaffm@gmail.com. ORCID: 0000-0002-8746-8727.
Similar Articles